Adicet Bio, Inc. (ACET) vs Gain Therapeutics, Inc. (GANX)

Adicet Bio, Inc. and Gain Therapeutics, Inc. are both Biotechnology companies. Adicet Bio, Inc. and Gain Therapeutics, Inc. are of similar size ($80.3M and $77.4M). Adicet Bio, Inc. grew revenue faster over the last twelve months: 224.6% against 18.4%. Across the 14 metrics below, Adicet Bio, Inc. leads on 8 and Gain Therapeutics, Inc. on 6.

Valuation

Metric ACET GANX Biotechnology median
P/E n/m n/m 7.88
P/S 2.50 397.40 11.47
P/B 0.81 6.87 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.20 n/m 0.74
EV/Sales (0.53) 332.17 10.73
Earnings yield (126.94%) (27.62%) (28.84%)
Free cash flow yield (87.66%) (24.45%) (23.03%)

Profitability

Metric ACET GANX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (78.08%) (268.30%) (57.72%)
Return on assets (63.62%) (159.22%) (49.22%)
Return on invested capital (2,518.16%) 0.00% 0.00%

Growth

Metric ACET GANX Biotechnology median
Revenue growth (TTM) 224.62% 18.36% 5.64%
EPS growth (last fiscal year) 20.35% 31.46% —
Revenue growth, 5-year CAGR 6.90% 21.79% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACET GANX Biotechnology median
Debt to equity 0.01 0.03 0.00
Current ratio 6.71 4.36 4.73
Net debt to EBITDA 1.32 1.10 0.96

Dividend

Metric ACET GANX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ACET GANX Biotechnology median
Market cap 77.42m 80.30m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack